SPR001

DRUG2 trials

Sponsors

Spruce Biosciences

Conditions

CAH - 21-Hydroxylase DeficiencyCAH - Congenital Adrenal HyperplasiaCongenital Adrenal Hyperplasia

Phase 2

Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

CompletedNCT03257462

Spruce BiosciencesCAH - Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia

Start: 2017-07-12End: 2019-03-29Updated: 2025-10-22

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

CompletedNCT03687242

Spruce BiosciencesCAH - 21-Hydroxylase Deficiency, CAH - Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia

Start: 2018-09-06End: 2019-08-09Updated: 2025-04-01